Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71205-304 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71205-304-60 - pregabalin caps 75mg 90s count

71205-304-60 - pregabalin caps 75mg 90s count

This is a medication called Pregabalin 75mg which comes in a bottle of 60 capsules. Each of the capsules has the drug name, dosage and company logo imprinted on them. The drug is made by a company called ScieGen Pharmaceuticals Inc. and packaged by Proficent Rx LP. It should be stored at 25°C and kept out of reach of children. The text also includes the lot number and expiration date of the drug. A medication guide should be provided to each patient receiving this drug. *

Figure 1 - pregabalin fig01

Figure 1 - pregabalin fig01

The text seems to be a table displaying some percentages related to patients' improvement regarding pain. The first line shows "Percent of Patients Improved" and the second line shows some digits ranging from 0 to 8. It is unclear what they represent without any context or further information available. The third line shows some non-English characters along with the digit "3". The fourth line contains a letter "o" and a non-English character, and the fifth line shows a word "Shemmm" and some spaces. The sixth line is empty. The seventh line contains some digits "2" and "0" forming a sequence. The last line shows "Percent Improvement in Pain fom Baseline". As the text is fragmented and mostly unreadable, it is not possible to derive any specific or useful description from it.*

Figure 2 - pregabalin fig02

Figure 2 - pregabalin fig02

Figure 3 - pregabalin fig03

Figure 3 - pregabalin fig03

This appears to be a chart or table displaying the percentage of patients who experienced improvement in their pain levels while taking different doses of Pregabalin and Gabapentin medications. The first line shows different dosages of Pregabalin (300mg, 160mg, and 75mg) taken two or three times per day. The second line appears to be cut off and no context is given for "Flaosbo." The last line shows percentages of improvement in pain levels from a baseline measurement. The numbers appear to be cut off and difficult to read, though they are possibly in the range of 20-88%.*

Figure 4 - pregabalin fig04

Figure 4 - pregabalin fig04

Figure 5 - pregabalin fig05

Figure 5 - pregabalin fig05

Figure 6 - pregabalin fig06

Figure 6 - pregabalin fig06

Figure 7 - pregabalin fig07

Figure 7 - pregabalin fig07

Figure 9 - pregabalin fig08

Figure 9 - pregabalin fig08

Figure 10 - pregabalin fig09

Figure 10 - pregabalin fig09

This is a table showing estimated percentages of subjects without LTR (late treatment response) for a drug called Progabain and placebo over a span of 120 days. The percentages range from 0% to 100%.*

Figure 11 - pregabalin fig10

Figure 11 - pregabalin fig10

The text is not available as it only includes gibberish characters and a number "00".*

Figure 12 - pregabalin fig11

Figure 12 - pregabalin fig11

Cockcroft and Gault equation - pregabalin formula

Cockcroft and Gault equation - pregabalin formula

This text provides a formula to calculate the CLCT (creatinine clearance) for patients based on their age, weight, and serum creatinine level. The formula involves subtracting the patient's age from 140, multiplying by their weight in kilograms, and then multiplying again by 0.85 for female patients. The result is then calculated by multiplying 72 by the patient's serum creatinine level measured in mg/dL.*

Chemical Structure - pregabalin str

Chemical Structure - pregabalin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.